Foresight Diagnostics
Giselle Zamora-Chavez is a skilled professional with extensive experience in laboratory settings, currently serving as a Production Shift Lead at Foresight Diagnostics since July 2023, where responsibilities include providing technical guidance and optimizing shift production operations. Previously, Giselle held the position of Research Associate II, focusing on optimizing and validating NGS assays for oncology applications. At the University of Colorado Anschutz Medical Campus, Giselle worked as a Research Service Professional, performing library preparation assays for next-generation sequencing. With prior roles at Invitae as a Genomic Technologist and ArcherDX, Giselle has developed expertise in assay development, regulatory compliance, and data analysis. Giselle earned a Bachelor of Science in Chemical and Biochemical Engineering from the Colorado School of Mines.
This person is not in any teams
This person is not in any offices
Foresight Diagnostics
1 followers
Foresight Diagnostics is the world’s most sensitive liquid biopsy minimal residual disease (MRD) test that detects the earliest hints of cancer relapse.